Nice find. Do the bylaws indicate what percentage a supermajority constitutes? I'm thinking at least 60%, maybe 67%, but OncoSec needs to make it clear.
Lincoln - Thanks for that information. Based on your information - when combined with DOC's statement in the PR that ONCS does not have to accept a buyout offer from CGP - it appears that there indeed is something in the bylaws preventing CGP from moving forward to buyout ONCS if they only own 53%. Would be good to get confirmation from DOC/IR, but that appears to be the case. Thanks.